CHIR 99021, CAS [[252917-06-9]]

Artikelnummer: ISC-KS-260
Artikelname: CHIR 99021, CAS [[252917-06-9]]
Artikelnummer: ISC-KS-260
Hersteller Artikelnummer: KS-260
Alternativnummer: ISC-KS-260
Hersteller: Isca Biochemicals
Kategorie: Biochemikalien
Alternative Synonym: CT99021, Laduviglusib
CHIR 99021 is a potent and highly selective inhibitor of glycogen synthase kinase 3 (GSK-3), with IC50 values of 6.7 and 10 nM for GSK-3beta and GSK-3alpha respectively, and greater than >500-fold selectivity for GSK-3 over closely related kinases. CHIR 99021 in combination with other agents can be used to reprogram mouse embryonic fibroblasts into induced pluripotent stem cells (iPSCs) and can also enhance mouse and human embryonic stem cell (ESC) self-renewal and promote differentiation of human pluripotent stem cells (hPSCs) in cardiomyocytes. CHIR 99021 is used in a protocol to generate brain organoids from human iPSCs.
Molekulargewicht: 465.35
Reinheit: 99% by TLC, NMR conforms
Formulierung: White solid
CAS Nummer: [252917-06-9]
Formel: C22H18Cl2N8
Target-Kategorie: Kinases
Anwendungsbeschreibung: ProductType: Small molecules